ALENTIS THERAPEUTICS
Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.
ALENTIS THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.alentis.ch
Total Employee:
11+
Status:
Active
Total Funding:
72.5 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Euro ReCAPTCHA
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Innoskel
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.
StemSight
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Alentis Therapeutics
Bpifrance
Bpifrance investment in Series B - Alentis Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series B - Alentis Therapeutics
BioMedPartners
BioMedPartners investment in Series B - Alentis Therapeutics
Kinled Holding
Kinled Holding investment in Series B - Alentis Therapeutics
Jeito Capital
Jeito Capital investment in Series B - Alentis Therapeutics
Schroder Adveq
Schroder Adveq investment in Series B - Alentis Therapeutics
Pureos Bioventures
Pureos Bioventures investment in Series B - Alentis Therapeutics
Pureos Bioventures
Pureos Bioventures investment in Series A - Alentis Therapeutics
Schroder Adveq
Schroder Adveq investment in Series A - Alentis Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-03 | Alentis Therapeutics Appoints Dr. Andrea Pellacani as Chief Medical Officer |
Official Site Inspections
http://www.alentis.ch
- Host name: linux96.curanet.dk
- IP address: 94.231.106.215
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
